2023 annual financial data
Oramed Pharmaceuticals 2023 Operating margin
Oramed Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -1,176.79%.
Operating income was -15,769,000 USD and net income was 5,525,000 USD.
Operating cash flow was -10,295,000 USD.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,340,000 USD
- Operating income
- -15,769,000 USD
- Net income
- 5,525,000 USD
- Operating cash flow
- -10,295,000 USD